0001013606-16-000307.txt : 20160926 0001013606-16-000307.hdr.sgml : 20160926 20160926110340 ACCESSION NUMBER: 0001013606-16-000307 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160203 FILED AS OF DATE: 20160926 DATE AS OF CHANGE: 20160926 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENDOLOGIX INC /DE/ CENTRAL INDEX KEY: 0001013606 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 680328265 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MUSICK CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 9495957200 MAIL ADDRESS: STREET 1: 2 MUSICK CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: RADIANCE MEDICAL SYSTEMS INC /DE/ DATE OF NAME CHANGE: 19990122 FORMER COMPANY: FORMER CONFORMED NAME: CARDIOVASCULAR DYNAMICS INC DATE OF NAME CHANGE: 19960506 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chobotov Michael V. CENTRAL INDEX KEY: 0001605288 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-28440 FILM NUMBER: 161901482 MAIL ADDRESS: STREET 1: 3910 BRICKWAY BLVD. CITY: SANTA ROSA STATE: CA ZIP: 95403 4/A 1 wf-form4a_147490220789994.xml FORM 4/A X0306 4/A 2016-02-03 2016-03-02 0 0001013606 ENDOLOGIX INC /DE/ ELGX 0001605288 Chobotov Michael V. 3805 SKYFARM DRIVE SANTA ROSA CA 95403 0 1 0 0 Chief Technology Officer Common Shares 2016-02-03 4 A 0 116948 7.42 A 203269 D Due to an administrative error, the initial Form reflected a transaction date of February 29, 2016. However, the transaction date should have been February 3, 2016, the effective date of the merger of TriVascular Technologies, Inc. ("TriVascular") with the Issuer and the date on which the Reporting Person was deemed to receive the shares. The Reporting Person received the shares in exchange for shares of TriVascular common stock pursuant to the merger of TriVascular with the Issuer. Pursuant to the terms of the merger agreement each share of TriVascular common stock automatically converted into the right to receive 0.631 shares of common stock of the Issuer. On the effective date of the merger, the closing price of the Issuer's common stock was $7.42. Michael V. Chobotov by Timothy N. Brady, Attorney-in-Fact for Reporting Person 2016-09-26